Sagility Other Announcement

Sagility Dividend

Sagility Limited declared an interim dividend of ₹0.15 per equity share for the financial year 2026-27. The record date is set for October 30, 2026.

Sagility Results Update

Sagility Ltd reported Q2 FY27 revenue of ₹2,032.1 Crore, up 22.5% YoY. The company also declared an interim dividend of ₹0.15 per share.

Sagility Investor Presentation: Key Takeaways

Sagility reported strong Q2 FY27 performance with 22.5% YoY revenue growth and 26.3% adjusted EBITDA margin. Performance driven by organic expansion in payer segments and strategic acquisition of Chirok Health.

Sagility Q2 FY27 Results: Net Profit ₹284.2 Cr, Up 13.3% YoY

Sagility Ltd reported revenue from operations of ₹2,032 Cr (+22.5% YoY) and net profit of ₹284.2 Cr (+13.3% YoY) for Q2 FY27.

Key figure

Net profit ₹284.2 Cr · +13.3% YoY

Sagility Acquisition Worth ₹304.1 Cr

Sagility's US subsidiary is acquiring Chirok Health LLC for up to US$ 32.35 million. This 100% stake acquisition strengthens Sagility's provider segment capabilities.

Value

₹304.1 Cr

Sagility Board Meeting Date

Sagility Ltd disclosed its Board is scheduled for 22 Oct 2026 to consider Q1/H1 FY27 results and any interim dividend. No decision has been taken yet.

Mahindra & Mahindra Financial Services Other Announcement

Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.

ACME Solar Holdings Other Announcement

ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.

eMudhra Other Announcement

eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.

Aarti Pharmalabs Other Announcement

Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.

Sagarsoft (India) Other Announcement

Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.

Sadhana Nitro Chem Other Announcement

Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.